NCT04864483

Brief Summary

To examine effects of two approaches to sahoor meal consumption during Ramadan on blood sugar control and incidence of early day hypoglycemic episodes requring the discontinuation of fasting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 21, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

3 months

First QC Date

April 26, 2021

Last Update Submit

April 3, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of early day hypoglycemia

    To determine if taking insulin dose suhoor meal 90 minutes before dawn plus a predawn high protein snack is associated with less rates of hypoglycemia -(we will consider glucose level of 70 mg/dl ( 3.9 mmol/l) and below as the level of hypoglycemia - compared to taking insulin dose suhoor meal 15-30 minutes before dawn during fasting Ramadan in patietnts with T1DM on MDI or insulin pump

    1 month

Secondary Outcomes (6)

  • number of days fasting discontinued

    1 month

  • Hyperglycemia incidence during fasting

    1 month

  • Blood sugar control

    1 month

  • Incidence of complications

    1 month

  • Glucose variability

    1 month

  • +1 more secondary outcomes

Study Arms (2)

Early sahoor with predawn snack

EXPERIMENTAL

To take the Sahoor meal 1:30-2 hours before dawn with insulin dose then a pre-dawn snack with no insulin (Sahoor is the latest meal before starting the fast at dawn during the month of Ramadan. The intervention is meal timing in relation to start of fast and does not involve any medications).

Other: Meal timing in relation to time of starting the fast

Late Sahoor meal (within 30 minjted of dawn) with insulin dose

EXPERIMENTAL

To take sahoor meal as late as possi le with usual insulin dose (Sahoor is the latest meal before starting the fast at dawn during the month of Ramadan. The intervention is meal timing in relation to start of fast and does not involve any medications).

Other: Meal timing in relation to time of starting the fast

Interventions

as described

Early sahoor with predawn snackLate Sahoor meal (within 30 minjted of dawn) with insulin dose

Eligibility Criteria

Age14 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • DM type 1
  • Age \> 14 years
  • Diagnosis of type 1 DM of more than 6 months.
  • Committed to do SMBG or on CGM
  • On Multiple Daily Injections or insulin pumps
  • On carbohydrate counting for meal dosing
  • Have previously fasted Ramadan
  • Are willing to fast this year
  • Well educated about requirements for fasting Ramadan

You may not qualify if:

  • Cognitive impairment or learning disability
  • Renal and hepatic impairment
  • Adrenal insufficiency
  • Pregnancy
  • Alcohol consumption
  • Any diagnosed psychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KingAbullahIMRC

Jeddah, Western, 21423, Saudi Arabia

Location

MeSH Terms

Conditions

Hypoglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Reem M Alamoudi

    King Abdullah International Medical Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized cross over design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
CONSULTANT ENDOCRINOLOGY

Study Record Dates

First Submitted

April 26, 2021

First Posted

April 29, 2021

Study Start

March 21, 2021

Primary Completion

June 27, 2021

Study Completion

August 30, 2021

Last Updated

April 11, 2022

Record last verified: 2022-04

Locations